---
$id: https://graph.org.ai/products/commodity/51142554
$type: Product
source: UNSPSC
code: "51142554"
title: "Lisuride maleate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lisuride maleate

**UNSPSC Code**: 51142554
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C20H26N4O.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UV1635N8XW, chemically known as 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but more generally known as lisuride maleate, which bears US NIH Compound Identifier 28864. European Medicines Agency schedules Lisuride maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02940MIG. Most nations, for tariff and trade purposes, schedule lisuride maleate under HS 29396900 and SITC 54146. As of Q4 2014, LISURIDE MALEATE remains US FDA's Preferred Term for this commodity. SMILES: CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3C[NH]C4C3C(CCC4)C2=C1)C.C(=C\C(=O)O)\C(=O)O.

